8VQ3
CDK2-CyclinE1 in complex with allosteric inhibitor I-198.
This is a non-PDB format compatible entry.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 17-ID |
Synchrotron site | APS |
Beamline | 17-ID |
Temperature [K] | 98 |
Detector technology | PIXEL |
Collection date | 2023-02-08 |
Detector | DECTRIS EIGER X 9M |
Wavelength(s) | 1 |
Spacegroup name | P 41 21 2 |
Unit cell lengths | 101.388, 101.388, 151.613 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 45.230 - 1.840 |
R-factor | 0.2002 |
Rwork | 0.199 |
R-free | 0.21690 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.011 |
RMSD bond angle | 1.340 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 84.280 | 1.960 |
High resolution limit [Å] | 1.840 | 1.840 |
Rmerge | 0.091 | 4.490 |
Number of reflections | 68650 | 1043 |
<I/σ(I)> | 24.6 | 1.6 |
Completeness [%] | 86.5 | |
Redundancy | 26.7 | |
CC(1/2) | 0.999 | 0.649 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 295 | 0.21 M sodium citrate tribasic dihydrate, 19.09% PEG3350 |